# | PDB (Resolution Å) |
Site # | Ligand | EC number | GO terms | UniProt | PubMed | Binding affinity |
---|---|---|---|---|---|---|---|---|
1 | 4rwg:A (2.44) | BS01 | peptide | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
2 | 4rwg:A (2.44) | BS02 | GLC | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
3 | 4rwg:A (2.44) | BS03 | GLC | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
4 | 4rwg:B (2.44) | BS01 | peptide | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
5 | 4rwg:B (2.44) | BS02 | GLC | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
6 | 4rwg:B (2.44) | BS03 | GLC | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
7 | 4rwg:B (2.44) | BS04 | MG | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
8 | 4rwg:C (2.44) | BS01 | peptide | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
9 | 4rwg:C (2.44) | BS02 | GLC | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 | |
10 | 4rwg:C (2.44) | BS03 | GLC | ? | GO:0004930 ... | O60894 P0AEX9 Q16602 |
25982113 |